Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,641,116
-$8,065,268 QoQ
Shares Held
390,259
-66.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 639 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $133,273,930 across 24 Drug Manufacturers - Specialty & Generic names. HLN ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
493,507 | $35,463,413 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
34,012 | $18,428,721 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
81,460 | $13,729,267 | |
| 4 | TLRY |
Tilray Brands, Inc.
|
2,498,656 | $11,218,964 | |
| 5 | CRON |
Cronos Group Inc.
|
3,767,849 | $10,474,620 | |
| 6 | CGC |
Canopy Growth Corp
|
9,189,630 | $8,730,148 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
317,878 | $7,822,977 | |
| 8 | VTRS |
Viatris Inc
|
354,486 | $5,629,237 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,641,116 | 390,259 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,706,384 | 1,169,469 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,498,831 | 1,434,108 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,774,551 | 1,312,659 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,313,680 | 898,137 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $132,483 | 12,875 | Shares | Sole | 2025-05-14 | |
| 2023-06-30 | $89,439 | 10,673 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||